Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
13.64
-0.94 (-6.45%)
Sep 10, 2026, 12:44 PM CST

SHE:002907 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
74.1265.0976.7332.798.491.78
Depreciation & Amortization
90.5786.2786.9482.1174.6969.84
Other Amortization
6.55.12.451.281.10.57
Loss (Gain) From Sale of Assets
-10.25-10.25--0.06--
Asset Writedown & Restructuring Costs
0.210.440.031.874.770.15
Loss (Gain) From Sale of Investments
7.1-9.69-1.384.672.611.33
Provision & Write-off of Bad Debts
0.20.21.41---
Other Operating Activities
-17.14-12.42-1.220.9514.4218.22
Change in Accounts Receivable
-46.55-79.84-30.384.86-85.87-16.39
Change in Inventory
0.261.4110.59-38.0211.42-8.71
Change in Accounts Payable
2.0818.6717.2845.63-106.82-75.39
Operating Cash Flow
89.3862.24161.77219.3413.0482.85
Operating Cash Flow Growth
-28.23%-61.52%-26.25%1581.42%-84.25%-27.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-28.82-14.56-16.15-92.82-60.62-56.64
Sale of Property, Plant & Equipment
6.566.560---
Cash Acquisitions
4.865.31----
Divestitures
-----0
Investment in Securities
-22.85-195.72-94.94-65.0152.04-53
Other Investing Activities
-4.46-6.213.870.493.291.1
Investing Cash Flow
-44.72-204.62-107.21-157.34-5.29-108.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---70--
Long-Term Debt Issued
---0.2--
Total Debt Issued
---70.2--
Short-Term Debt Repaid
----70--12
Long-Term Debt Repaid
--0.16-0.14-0.26-2.19-0.03
Lease Payments
-0.58-0.16-0.14-0.22-0.15-0.03
Total Debt Repaid
5.45-0.16-0.14-70.26-2.19-12.03
Net Debt Issued (Repaid)
5.45-0.16-0.14-0.06-2.19-12.03
Repurchase of Common Stock
-----7.11-0.23
Common Dividends Paid
-31.32-35.5-35.5-30.17-23.04-13.4
Other Financing Activities
-4.09-4.09----
Financing Cash Flow
-29.96-39.74-35.63-30.23-32.35-25.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.09-0.10.060.070.35-0.09
Net Cash Flow
14.61-182.2118.9931.84-24.24-51.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
60.5547.68145.62126.52-47.5726.21
Free Cash Flow Growth
-45.62%-67.25%15.09%---60.85%
Free Cash Flow Margin
7.58%5.76%18.79%18.30%-6.06%3.10%
Free Cash Flow Per Share
0.140.110.350.30-0.120.07
Levered Free Cash Flow
54.2982.48117.9631.021.63-2.62
Unlevered Free Cash Flow
55.4482.57117.9631.6110.648.77
Free Cash Flow After Leases
59.9747.52145.48126.3-47.7326.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
0.90.9----
Cash Income Tax Paid
99.82103.6980.8280.7660.6889.24
Change in Working Capital
-61.94-62.5-3.295.83-182.95-99.04